single X-ray crystallography. The in vitro cytotoxicity of the prepared Cu(II) complexes was evaluated against A2780 (ovarian), A2780R (cisplatin-resistant variant) and MCF7 (breast cancer) human cancer cell lines. Overall, the complexes revealed significant-to-moderate cytotoxicity, with the best results obtained for the complexes [Cu(BQPA)Cl]ClO4 (5-ClO4) and [Cu(BQPA)Cl]PF6 (5-PF6), showing IC50 values
的配合物[
铜(
TPA)CL] CLO 4 ·½H 2 O(1-CLO 4),[Cu(上6- Me
TPA)CL] CLO 4 / PF 6( 2-CLO 4 / 2-PF 6),[
铜(6-Me 2
TPA)Cl] PF 6(3-PF 6),[Cu(BPQA)Cl] ClO 4 / PF 6(4-ClO 4 / 4-PF 6),[Cu(BPQA)Cl] ClO 4 / PF 6(4-ClO 4 / 4-PF 6),[Cu(BQPA)Cl] ClO 4 / PF 6(5-ClO 4 / PF 6),[Cu(L 1)Cl] ClO 4 / PF 6(6-ClO 4 / 6-PF 6),[Cu(L 2)Cl] ClO 4(7-ClO 4)合成了[Cu(L 3)Cl] ClO 4(8-ClO 4),并通过光谱技术和单X射线晶体学对其结构进行了表征。在体外的细胞毒性所制备的
铜(II)针对A2780(卵巢